| Schizophrenia |
1 |
0.48 |
| Antipsychotics |
0 |
0.29 |
| Mental Illness |
0 |
0.29 |
| Cognitive Behavioral Therapy |
0 |
0.27 |
| Biomarker |
0 |
0.24 |
| Jobs |
0 |
0.11 |
| Meta-Analysis |
0 |
0.11 |
| Preventive Screening |
0 |
0.11 |
| Pregnancy |
0 |
0.09 |
| Depression |
0 |
0.08 |
| Disability |
0 |
0.08 |
| Quality of Life |
0 |
0.08 |
| Stress |
0 |
0.08 |
| Biologic Therapy |
0 |
0.07 |
| Revenue and Practice Management |
0 |
0.07 |
| Substance Abuse |
0 |
0.07 |
| Cancer in Childhood |
0 |
0.06 |
| Abuse |
0 |
0.05 |
| Adherence |
0 |
0.05 |
| Child |
0 |
0.05 |
| Fatty Acids |
0 |
0.05 |
| Psychosocial |
0 |
0.05 |
| Remission |
0 |
0.05 |
| Social Determinants of Health |
0 |
0.05 |
| Stigma |
0 |
0.05 |
| Academia |
0 |
0.04 |
| Acute Leukemia |
0 |
0.04 |
| Acute Lymphoblastic Leukemia |
0 |
0.04 |
| Genomic Medicine |
0 |
0.04 |
| Patient Safety |
0 |
0.04 |
| Adverse Effects |
0 |
0.03 |
| Antidepressant drug |
0 |
0.03 |
| Antioxidant |
0 |
0.03 |
| Anxiety |
0 |
0.03 |
| Anxiety Disorder |
0 |
0.03 |
| Cancer |
0 |
0.03 |
| Cardiovascular Imaging |
0 |
0.03 |
| Case Management |
0 |
0.03 |
| Delusions |
0 |
0.03 |
| Echocardiography |
0 |
0.03 |
| Evidence-Based Medicine |
0 |
0.03 |
| Exercise |
0 |
0.03 |
| Health Care Economics |
0 |
0.03 |
| Health Care Organizations |
0 |
0.03 |
| Health Care Reform |
0 |
0.03 |
| Health Maintenance Organization |
0 |
0.03 |
| Hospital |
0 |
0.03 |
| Impairment |
0 |
0.03 |
| Isolation |
0 |
0.03 |
| Leukemia |
0 |
0.03 |
| Outpatient Clinic |
0 |
0.03 |
| Oxytocin |
0 |
0.03 |
| Pharmacogenomics |
0 |
0.03 |
| Pituitary Gland |
0 |
0.03 |
| Primary Care |
0 |
0.03 |
| Private Practice |
0 |
0.03 |
| Psychotherapy |
0 |
0.03 |
| Receptors |
0 |
0.03 |
| Referral |
0 |
0.03 |
| Salary and Compensation |
0 |
0.03 |
| Vasopressin |
0 |
0.03 |
| Weight Gain |
0 |
0.03 |
| Weight Management |
0 |
0.03 |